Literature DB >> 23756337

Current thoughts and developments in facial nerve reanimation.

Callum Faris1, Robin Lindsay.   

Abstract

PURPOSE OF REVIEW: To present the most current literature regarding the management of acute and chronic facial paralysis. This review will focus primarily on smile reanimation in the setting of acute and chronic facial paralysis. The management of the flaccid and the hypertonic face will be discussed. RECENT
FINDINGS: Recent developments include advances in neural repair with fibrin glue and the use of cadaveric nerve grafts as interposition grafts. Advances in nerve substitutes have been shown to limit donor-site morbidity and provide similar outcomes to autografts. Techniques for muscle transfer continue to evolve to improve smile outcomes.
SUMMARY: The goal of facial reanimation surgery is to restore meaningful facial movement. The goal should be to have quality-driven clinical practice guidelines to better facilitate patient care. This process must be initiated by facial reanimation surgeons deciding to use consistent outcome measures to report their results. Currently, it is impossible to make a direct comparison between different surgical techniques because of inconsistent methods of evaluation. Despite the lack of consistent quantitative evaluation, there have been many exciting advances in the field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756337     DOI: 10.1097/MOO.0b013e328362a56e

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Effect of FK506 on apoptosis of facial motor neurons in rats and its possible mechanism.

Authors:  Ying Zhang; Ruoyu Zhang; Song Qiao; Jing Fan
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-18       Impact factor: 2.503

Review 2.  Update in facial nerve paralysis: tissue engineering and new technologies.

Authors:  Nicholas B Langhals; Melanie G Urbanchek; Amrita Ray; Michael J Brenner
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2014-08       Impact factor: 2.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.